Pigmentation Disorders: Diagnosis and Management
- PMID: 29431372
Pigmentation Disorders: Diagnosis and Management
Abstract
Pigmentation disorders are commonly diagnosed, evaluated, and treated in primary care practices. Typical hyperpigmentation disorders include postinflammatory hyperpigmentation, melasma, solar lentigines, ephelides (freckles), and café au lait macules. These conditions are generally benign but can be distressing to patients. Appropriate dermatologic history, skin examination, and skin biopsy, when appropriate, can help exclude melanoma and its precursors. In addition to addressing the underlying condition, hyperpigmentation is treated with topical agents, chemical peels, cryotherapy, light or laser therapy, or a combination of these methods. Café au lait macules are treated with surgical excision or laser therapy if treatment is desired. Hypopigmentation disorders include vitiligo, pityriasis alba, tinea versicolor, and postinflammatory hypopigmentation. Treatment of vitiligo depends on the distribution and extent of skin involvement, and includes topical corticosteroids and calcineurin inhibitors, ultraviolet A therapy (with or without psoralens), narrowband ultraviolet B therapy, and cosmetic coverage. Patients with stable, self-limited vitiligo may be candidates for surgical grafting techniques, whereas those with extensive disease may be candidates for depigmentation therapy to make skin tone appear more even. Other hypopigmentation disorders may improve or resolve with treatment of the underlying condition.
Similar articles
-
Common pigmentation disorders.Am Fam Physician. 2009 Jan 15;79(2):109-16. Am Fam Physician. 2009. PMID: 19178061
-
Common hyperpigmentation disorders in adults: Part II. Melanoma, seborrheic keratoses, acanthosis nigricans, melasma, diabetic dermopathy, tinea versicolor, and postinflammatory hyperpigmentation.Am Fam Physician. 2003 Nov 15;68(10):1963-8. Am Fam Physician. 2003. PMID: 14655805 Review.
-
Common disorders of pigmentation: when are more than cosmetic cover-ups required?Postgrad Med. 1996 Jun;99(6):177-86. Postgrad Med. 1996. PMID: 8668630 Review.
-
Common hyperpigmentation disorders in adults: Part I. Diagnostic approach, café au lait macules, diffuse hyperpigmentation, sun exposure, and phototoxic reactions.Am Fam Physician. 2003 Nov 15;68(10):1955-60. Am Fam Physician. 2003. PMID: 14655804 Review.
-
Laser eradication of pigmented lesions: a review.Dermatol Surg. 2011 May;37(5):572-95. doi: 10.1111/j.1524-4725.2011.01971.x. Epub 2011 Apr 14. Dermatol Surg. 2011. PMID: 21492309 Review.
Cited by
-
A Novel Combination of BroadBand Light (BBL® HEROTM) and Nonablative Fractionated 1,927nm (MOXITM) Laser for Addressing Solar Lentigines.J Clin Aesthet Dermatol. 2024 Sep-Oct;17(9-10 Suppl 1):S36-S39. J Clin Aesthet Dermatol. 2024. PMID: 39386001 Free PMC article.
-
Emerging lasers and light-based therapies in the management of acne: a review.Lasers Med Sci. 2024 Sep 28;39(1):245. doi: 10.1007/s10103-024-04196-8. Lasers Med Sci. 2024. PMID: 39340675 Free PMC article. Review.
-
Efficacy and Best Mode of Delivery for Tranexamic Acid in Post-Inflammatory Hyperpigmentation: A Systematic Review.Clin Cosmet Investig Dermatol. 2022 Dec 28;15:2873-2882. doi: 10.2147/CCID.S394889. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36597522 Free PMC article.
-
Treatment of Post-Inflammatory Hyperpigmentation in Skin of Colour: A Systematic Review.J Cutan Med Surg. 2024 Sep-Oct;28(5):473-480. doi: 10.1177/12034754241265716. Epub 2024 Jul 29. J Cutan Med Surg. 2024. PMID: 39075672 Free PMC article.
-
The small molecule ML233 is a direct inhibitor of tyrosinase function.bioRxiv [Preprint]. 2025 Feb 20:2025.02.16.638443. doi: 10.1101/2025.02.16.638443. bioRxiv. 2025. Update in: Commun Biol. 2025 Mar 28;8(1):506. doi: 10.1038/s42003-025-07973-5. PMID: 40027619 Free PMC article. Updated. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous